Sterling Investment Advisors (Pennsylvania)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,000
| Closed | -$8K | – | 474 |
|
|
2022
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 425 |
|
|
2022
Q1 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 450 |
|
|
2021
Q4 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 460 |
|
|
2021
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 437 |
|
|
2021
Q2 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 423 |
|
|
2021
Q1 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 391 |
|
|
2020
Q4 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 369 |
|
|
2020
Q3 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 352 |
|
|
2020
Q2 | $12K | Hold |
1,000
| – | – | 0.01% | 331 |
|
|
2020
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 328 |
|
|
2019
Q4 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 344 |
|
|
2019
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 362 |
|
|
2019
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 356 |
|
|
2019
Q1 | $16K | Hold |
1,000
| – | – | 0.01% | 312 |
|
|
2018
Q4 | $15K | Hold |
1,000
| – | – | 0.01% | 304 |
|
|
2018
Q3 | $22K | Hold |
1,000
| – | – | 0.01% | 300 |
|
|
2018
Q2 | $24K | Hold |
1,000
| – | – | 0.01% | 278 |
|
|
2018
Q1 | $17K | Hold |
1,000
| – | – | 0.01% | 286 |
|
|
2017
Q4 | $19K | Hold |
1,000
| – | – | 0.01% | 263 |
|
|
2017
Q3 | $18K | Sell |
1,000
-2,900
| -74% | -$52.2K | 0.01% | 262 |
|
|
2017
Q2 | $130K | Hold |
3,900
| – | – | 0.09% | 122 |
|
|
2017
Q1 | $125K | Buy |
3,900
+100
| +3% | +$3.21K | 0.09% | 115 |
|
|
2016
Q4 | $138K | Buy |
+3,800
| New | +$138K | 0.11% | 98 |
|